Serge Holz
Papers
5
Total Citations
48
H-Index
4
About
Serge Holz is a urologic surgeon and researcher whose work centers on advancing the surgical management of bladder cancer, with a particular focus on robot-assisted radical cystectomy (RARC) and intracorporeal urinary diversion (ICUD). His major contributions include pioneering cost-effectiveness analyses of robotic cystectomy across European healthcare systems, demonstrating that while the technology is expensive, its adoption can be justified through reduced morbidity and shorter hospital stays. Holz has also been instrumental in refining postoperative outcome measurement, notably through the adoption of the Comprehensive Complication Index (CCI) to more accurately capture the cumulative burden of complications after cystectomy—a significant improvement over the traditional Clavien-Dindo system. His research on perioperative blood transfusions and anticoagulation management has provided critical safety data, showing that continuing acetylsalicylic acid during robotic cystectomy does not increase hemorrhagic risks. With papers accumulating over 50 citations, Holz has established himself as a key voice in evidence-based robotic urologic oncology. His work on Zinner syndrome, though rare, demonstrates his breadth, applying robotic techniques to complex congenital anomalies.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5